James Knight

James Knight

Corporate Officer/Principal chez SYNACT PHARMA AB

Fortune : 50 077 $ au 31/05/2024

Health Technology
Consumer Services
Finance

Profil

James Knight's current job(s) include being the Chief Business Officer at SynAct Pharma AB, the Chief Business Officer at TXP Pharma GmbH, and the Head-Business Development at Biora Therapeutics, Inc. Mr. Knight's former job(s) include being the Director-Healthcare Consulting at Datamonitor, Inc., the Principal at Dura Pharmaceuticals, Inc., the Senior Vice President & Head-Corporate Development at Lineage Cell Therapeutics, Inc., and the Associate Scientist at Biogen, Inc. Additionally, he served as the Vice President-Portfolio Strategy at Questcor Pharmaceuticals, Inc. from 2010 to 2014, and as the Vice President-Global Strategic Marketing at Elan Pharmaceuticals LLC from 2001 to 2008.
Mr. Knight's education history includes obtaining an MBA from Northeastern University and an undergraduate degree from the University of Massachusetts.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/06/2023 77 452 ( 0,19% ) 50 077 $ 31/05/2024

Postes actifs de James Knight

SociétésPosteDébut
SYNACT PHARMA AB Corporate Officer/Principal 11/02/2021
BIORA THERAPEUTICS, INC. Corporate Officer/Principal -
TXP Pharma GmbH Corporate Officer/Principal -
Tous les postes actifs de James Knight

Anciens postes connus de James Knight

SociétésPosteFin
QUESTCOR PHARMACEUTICALS INC Corporate Officer/Principal 01/01/2014
Sales & Marketing 01/01/2008
LINEAGE CELL THERAPEUTICS, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de James Knight

Formation de James Knight

Northeastern University Masters Business Admin
University of Massachusetts Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Knight

Relations

86

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
LINEAGE CELL THERAPEUTICS, INC.

Health Technology

BIOGEN INC.

Health Technology

SYNACT PHARMA AB

Health Technology

BIORA THERAPEUTICS, INC.

Health Services

Entreprise privées5

Health Technology

Health Technology

Health Technology

Finance

TXP Pharma GmbH

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Knight